| Non‐thermal plasma as a unique delivery system of short‐lived reactive oxygen and nitrogen species for immunogenic cell death in melanoma cells A Lin, Y Gorbanev, J De Backer, J Van Loenhout, W Van Boxem, ... Advanced Science 6 (6), 1802062, 2019 | 199 | 2019 |
| The influence of cell type and culture medium on determining cancer selectivity of cold atmospheric plasma treatment E Biscop, A Lin, W Van Boxem, J Van Loenhout, J De Backer, C Deben, ... Cancers 11 (9), 1287, 2019 | 97 | 2019 |
| Cold atmospheric plasma-treated PBS eliminates immunosuppressive pancreatic stellate cells and induces immunogenic cell death of pancreatic cancer cells J Van Loenhout, T Flieswasser, L Freire Boullosa, J De Waele, ... Cancers 11 (10), 1597, 2019 | 96 | 2019 |
| Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer LF Boullosa, J Van Loenhout, T Flieswasser, J De Waele, C Hermans, ... Redox biology 42, 101949, 2021 | 78 | 2021 |
| Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells JRM Van Audenaerde, J De Waele, E Marcq, J Van Loenhout, E Lion, ... Oncotarget 8 (34), 56968, 2017 | 65 | 2017 |
| Oxidative stress-inducing anticancer therapies: Taking a closer look at their immunomodulating effects J Van Loenhout, M Peeters, A Bogaerts, E Smits, C Deben Antioxidants 9 (12), 1188, 2020 | 50 | 2020 |
| Poly (I: C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade J De Waele, E Marcq, JRM Van Audenaerde, J Van Loenhout, C Deben, ... Oncoimmunology 7 (3), e1407899, 2018 | 50 | 2018 |
| Clinically relevant chemotherapeutics have the ability to induce immunogenic cell death in non-small cell lung cancer T Flieswasser, J Van Loenhout, L Freire Boullosa, A Van den Eynde, ... Cells 9 (6), 1474, 2020 | 43 | 2020 |
| Auranofin and cold atmospheric plasma synergize to trigger distinct cell death mechanisms and immunogenic responses in glioblastoma J Van Loenhout, L Freire Boullosa, D Quatannens, J De Waele, C Merlin, ... Cells 10 (11), 2936, 2021 | 39 | 2021 |
| Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment JRM Van Audenaerde, E Marcq, B von Scheidt, AS Davey, AJ Oliver, ... Clinical & translational immunology 9 (8), e1165, 2020 | 30 | 2020 |
| Building a bridge between chemotherapy and immunotherapy in malignant pleural mesothelioma: investigating the effect of chemotherapy on immune checkpoint expression E Marcq, JRM Van Audenaerde, J De Waele, J Jacobs, J Van Loenhout, ... International journal of molecular sciences 20 (17), 4182, 2019 | 11 | 2019 |
| Auranofin synergizes with the PARP inhibitor olaparib to induce ROS-mediated cell death in mutant p53 cancers L Freire Boullosa, J Van Loenhout, T Flieswasser, C Hermans, C Merlin, ... Antioxidants 12 (3), 667, 2023 | 8 | 2023 |
| Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy? H Zaryouh, J Van Loenhout, M Peeters, JB Vermorken, F Lardon, ... Cancers 14 (24), 6128, 2022 | 4 | 2022 |
| Immunogenic Potential Of Cold Atmospheric Plasma For The Treatment Of Pancreatic Cancer J Van Loenhout, C Deben, J Jacobs, J De Waele, J Van Audenaerde, ... Clinical Plasma Medicine 9, 26, 2018 | 3 | 2018 |
| Optimization of the solvent and in vivo administration route of auranofin in a syngeneic non-small cell lung cancer and glioblastoma mouse model L Freire Boullosa, J Van Loenhout, C Hermans, HW Lau, C Merlin, ... Pharmaceutics 14 (12), 2761, 2022 | 2 | 2022 |
| PO-419 Poly (I: C) prepares glioblastoma cells for anti-PD-L1 therapy via lymphocyte attraction and activation in a TLR3-dependent manner J De Waele, E Marcq, J Van Audenaerde, J Van Loenhout, C Deben, ... ESMO Open 3, A394-A395, 2018 | 2 | 2018 |
| Unraveling the in vivo therapeutic potential of auranofin and cold atmospheric plasma in glioblastoma J Van Loenhout Targeting pancreatic ductal adenocarcinoma and glioblastoma with oxidative …, 2021 | | 2021 |
| Targeting pancreatic ductal adenocarcinoma and glioblastoma with oxidative stress-mediated treatment strategies: focus on tumor cell death and modulation of the tumor … J Van Loenhout University of Antwerp, 2021 | | 2021 |
| Endogenous antioxidants in the prognosis and treatment of lung cancer LF Boullosa, J Van Loenhout, C Deben Cancer, 39-48, 2021 | | 2021 |
| 453 Novel combination immunotherapy for boosting and priming immune responses in pancreatic cancer: strong anti-tumour effects with interleukin-15 and CD40 agonist treatment J Van Audenaerde, E Marcq, B von Scheidt, A Davey, A Oliver, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
